DAX23.689 +0,7%ESt505.490 +0,8%Top 10 Crypto14,99 -1,8%Dow46.085 +0,3%Nas22.339 -0,2%Bitcoin93.177 -0,3%Euro1,1693 +0,3%Öl70,46 +1,2%Gold3.777 +0,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 NVIDIA 918422 Novo Nordisk A3EU6F Intel 855681 Tesla A1CX3T Lufthansa 823212 SAP 716460 Siemens Energy ENER6Y HENSOLDT HAG000 DroneShield A2DMAA BYD A0M4W9 Plug Power A1JA81 Volkswagen (VW) vz. 766403 Alibaba A117ME
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX in Grün -- Wall Street uneins -- Höhere Trump-Zölle auf Arzneimittel & Co. -- Gerresheimer, Intel, Plug Power, Siemens, Rheinmetall, D-Wave, Droneshield, Oracle im Fokus
Top News
Darum tendieren die Ölpreise leicht im Plus Darum tendieren die Ölpreise leicht im Plus
Eckert und Ziegler: Zölle drohen Eckert und Ziegler: Zölle drohen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Fulcrum Therapeutics Aktie

Kaufen
Verkaufen
8,71 USD +0,20 USD +2,35 %
BTT
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.382,13 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PM28

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS3596161097

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolFULC

Fulcrum Therapeutics Aktien News

DatumMeistgelesen
ZacksFulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why
BenzingaExpert Ratings For Fulcrum Therapeutics
BenzingaEarnings Preview: Fulcrum Therapeutics
ZacksDown -57.53% in 4 Weeks, Here's Why Fulcrum Therapeutics (FULC) Looks Ripe for a Turnaround
PR NewswireFULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!
PR NewswireFULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC
PR NewswireFULC Investors Have Opportunity to Lead Fulcrum Therapeutics, Inc. Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2023 - (NASDAQ: FULC)
PR NewswireROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC
PR NewswireFULC INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC
PR NewswireROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULC
PR NewswireFULC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2023 in the Class Action Filed on Behalf of Fulcrum Therapeutics, Inc. Shareholders
PR NewswireROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULC
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC
PR NewswireFULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FULC
PR NewswireFULC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2023 in the Class Action Filed on Behalf of Fulcrum Therapeutics, Inc. Shareholders
PR NewswireInvestor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of Class Action and to Actively Participate
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulcrum Therapeutics, Inc. - FULC

Fulcrum Therapeutics News

Fulcrum Therapeutics News: auf dieser Seite finden Sie alle Fulcrum Therapeutics News und Nachrichten zur Fulcrum Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Fulcrum Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Fulcrum Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.